Press Releases
Discover the Growth of the Gene Therapy Market

, 12 January 2018 -- Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Gene therapy is an experimental medical treatment that uses specific types of genes to treat or prevent several types of diseases. Gene therapy is also used to treat several hereditary diseases, wherein the mutated defective gene is replaced with the functional gene. Gene therapy is being widely studied by researchers all over the world for the treatment of several diseases such as immune deficiencies, hemophilia, Parkinson’s disease, cancer, and even HIV, through different approaches. Three primary approaches that are being studied and practiced in the gene therapy are replacement of the mutated disease-causing gene with the healthy gene, inactivation of the mutated gene, and introduction of the new gene to fight against the disease. In the gene therapy treatment, a functional gene is inserted into the genome of an individual’s cells and tissues by using a carrier known as ‘vector’. Viruses is the most common type of vectors used in gene therapy, which is genetically altered to carry the normal human DNA. Over the last few years, gene therapy has emerged as a promising treatment option for several diseases including inherited disorders and certain types of cancers and viral infections. However, the treatment is still reviewed for its effectiveness and safety. Currently, the gene therapy is being tested only for those diseases for which no other treatment is available.

The demand for gene therapy is greatly influenced by the increasing number of patients with cancer, hereditary disorders, and viral infections. The International Agency for Research on Cancer has estimated that more than 21.7 million cases of cancer are likely to be diagnosed worldwide and more than 13 million deaths would occur due to cancer across the world by the end of 2030. Moreover, according to Joint United Nations Programme on HIV and AIDS () in 2015, there were approximately 36.7 million people living with HIV/AIDS across the globe. Technological advancements and several pre-clinical and clinical trials for the treatment of different disease are likely to boost the gene therapy market during the forecast period. Also, successful clinical trials of gene therapy for the treatment of central nervous system disorders would open new avenues for the global gene therapy market in the near future. Moreover, increase in R&D budgets by commercial players and governments for the development of safe and effective gene therapy for various diseases would propel the global gene therapy market in the near future. However, high cost of gene therapy treatment and unwanted immune response in some cases are some of the restraining factors for the market.

The global gene therapy market can be broadly segmented based on type of gene therapy, type of vector used for gene transfer, disease indication, and geography. Basically, there exist two types of gene therapy: germline gene therapy (which involves the modification of genes inside the germ cells i.e. sperms and ova) and somatic gene therapy (where the therapeutic gene is inserted into the body cells or tissues and not in germ cells or gametes). The somatic gene therapy is widely studied and practiced for the treatment of cancer and infectious diseases. Use of the germline gene therapy for the treatment of hereditary disorders is prohibited in countries such as Germany, Switzerland, and Australia, due to and long-term effects on the future generation. Based on type of vector used, the market has been segmented into viral vectors and non-viral vectors such as bacteria and plasmid DNA. Viral vectors are most commonly used and studied. The viral vectors segment accounts for a major share of the global gene therapy market. Based on indication, the global gene therapy market has been segmented into infectious diseases, genetic diseases, cancer, and other diseases.

Geographically, the global gene therapy market has been segmented into four regions: North America, Europe, Asia Pacific, and Rest of World. North America is projected to dominate the global gene therapy market by 2025. The major share held by North America is attributable to well-established health care facilities, high per capita health care expenditure, favorable medical reimbursement policies, and extensive R&D activities for the gene therapy in the region. Additionally, increasing number of patients with cancer and genetic disorders in the region is projected to propel the demand for gene therapy in North America during the forecast period. The market for gene therapy in North America is anticipated to expand at the maximum CAGR from 2017 to 2025. Europe is anticipated to follow North America in the market for gene therapy. The market in Asia Pacific is likely to expand at a moderate growth rate during the forecast period.

Download Report Brochure @

Key players operating in the global gene therapy market are Bluebird Bio, Inc., CELGENE CORPORATION, Adaptimmune Therapeutics plc, GlaxoSmithKline plc., Merck KGaA, OncoGenex Pharmaceuticals, Inc., Shanghai Sunway Biotech Co. Ltd., and Transgene SA. Most of these companies are witnessing different pre-clinical and clinical stages of development of gene therapies.

# # #

Submitted by Sandy Researcher, Transparency Market Research on Friday, 12 January 2018 at 8:05 PM
Category: Health Care & Medical
Related News

Professional Survey Report On Global Dental Restorative Materials Market | ResearchMoz
Wednesday, 12 Dec 2018

Global Diagnostic Reagents Market | Top Leading Vendors Such As Roche, Abbott
Wednesday, 12 Dec 2018

Global Clinical Data Analytics Market Research Analyst Focuses on Companies like Athenahealth
Wednesday, 12 Dec 2018

ResearchMoz: Growing Demand For Global Circulating Tumor Cell Market Size, Status and Forecast 2018
Wednesday, 12 Dec 2018

Global Bionic Exoskeletons Market Forecast By Top Leading Manufacturers | Ekso Bionics, Ottobock Inc
Wednesday, 12 Dec 2018

Related Events

5th Winter Process Chemistry Conference And Exhibition, Manchester, UK
Tuesday, 11 Dec 2018

The 38th Annual Meeting of the Israeli Orthopaedic Association, Tel-Aviv
Wednesday, 12 Dec 2018

3rd New Product Planning Summit
Wednesday, 12 Dec 2018

Tumor Targeted Lymphocyte Summit 2018 | Boston, MA | December 12-13, 2018
Wednesday, 12 Dec 2018

Advances in Inflammatory Bowel Diseases (AIBD) December 13-15, 2018
Thursday, 13 Dec 2018

Latest News

Thursday, 13 Dec 2018

Thursday, 13 Dec 2018

Global Emulsion Adhesives Market By Type - Acrylic Polymer Emulsion
Wednesday, 12 Dec 2018

Global Emission Control Catalyst Market Potential Competition By Players With Rising Growth
Wednesday, 12 Dec 2018

In-Depth Study On Current State Of Global Electric Power System Analysis Software Market
Wednesday, 12 Dec 2018

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Thursday, 13 December 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: Cyber Tuesday - Cyber Range Level 1
  • 5th Winter Process Chemistry Conference And Exhibition, Manchester, UK
  • Palo Alto Networks: Ultimate Test Drive - Threat Prevention
  • Palo Alto Networks: Get Hands-on with the VM-Series on Microsoft Azure
  • IEE International Conference on the Science of Electrical Engineering

  • Latest Jobs
    Sorry, there are currently no entries posted here.